Cambridge Bioscience is pleased to announce a new partnership with Novoprotein, a global leader in recombinant protein production and custom protein services. This collaboration brings Novoprotein’s extensive portfolio of high-quality, research-grade proteins to scientists throughout the UK and Ireland.
Novoprotein offers over 25,000 recombinant proteins covering a broad range of research areas including immunology, oncology, virology and drug development. With multiple expression systems and stringent quality control, Novoprotein delivers proteins with exceptional consistency and biological activity.
Through this partnership, Cambridge Bioscience aims to support researchers in academia, biotech and pharma by providing access to Novoprotein’s trusted protein reagents along with our expert support.
Learn more about Novoprotein or contact our Novoprotein specialists.